chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Dose 1,2,3,5 Comirnaty vaccine; Dose 4: Moderna vaccine; COVID 19 Treatment; COVID 19 Treatment; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 56-year-old female patient (not pregnant) received bnt162b2, bnt162b2 omi ba.4-5 (BNT162B2, BNT162B2 OMI BA.4-5), on 12Dec2022 as dose 5 (booster), single (Batch/Lot number: unknown) at the age of 55 years for covid-19 immunisation; bnt162b2 (BNT162B2), on 09Apr2021 as dose 1, single (Lot number: ER8729), on 30Apr2021 as dose 2, single (Lot number: EW0179) and on 30Nov2021 as dose 3 (booster), single (Lot number: 330308D) for covid-19 immunisation; elasomeran (COVID-19 VACCINE MODERNA), on 26Apr2022 as dose 4 (booster), single (Lot number: 005M21A) for covid-19 immunisation. The patient had no relevant medical history. Concomitant medication(s) included: OSSOPAN BMD, start date: 13Jan2021; MULTI-VITAMINS VITAFIT, start date: 13Jan2021; ESTROGEN, start date: 16Jan2023; VIT D3, start date: 13Jan2021; PROGESTERONE, start date: 16Jan2023. The following information was reported: VACCINATION FAILURE (medically significant), COVID-19 (medically significant) all with onset Sep2023, outcome "recovered" (21Sep2023) and all described as "COVID 19 Treatment"; INTERCHANGE OF VACCINE PRODUCTS (medically significant), outcome "recovered", described as "Dose 1,2,3,5 Comirnaty vaccine; Dose 4: Moderna vaccine". The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: (21Sep2023) Negative. Therapeutic measures were taken as a result of vaccination failure, covid-19 with Paxlovid from 16Sep2023 to 21Sep2023. Patient had no known allergies.  The information on the batch/lot number for bnt162b2, bnt162b2 omi ba.4-5 has been requested and will be submitted if and when received.
Narrative: COVID infection following COVID vaccine series 12/28/2020, Pfizer, dose #1 01/19/2021, Pfizer, dose #2 10/07/2021, Pfizer dose #3 09/07 cc: cough, diarrhea, fatigue, dyspnea exposure: unknown 09/09 COVID swab, result: detected
Approximately 11 hours after receiving the injection symptoms experienced included nausea, hypotension, loss of appetite, malaise and fatigue. symptoms lasted for 36 hours.
9/16/05 redness at site right arm cellulitis, Augmentin. 9/17/05 ER same Rocephin shot.
36 YO female presented for primary care intake exam on 07/23/2015.  Patient qualified for and was given Pneumovax 23.  Patient called primary care on 07/25/2015 with complaints of injection site being red and sore, having muscle aches, and a fever of 102.3°F.  Fever decreased with use of ibuprofen.  Patient instructed to continue use of pain reliever/fever reducer and to apply a warm moist pack to the arm and to seek medical care within 24 hours if the condition worsened.  Follow-up phone call to patient on 07/27/2015 revealed patient was seen at urgent care clinic and was treated with cephalexin 400mg and Medrol pack. Patient was told by urgent care clinic that she had cellulitis.
I received my second Covid vaccine on May 9, had a period starting on May 22 it resulted in pregnancy, miscarried pregnancy. No known documentation for pregnancy except for miscarriage there?s no pregnancy symptoms arose so I test was never taken. Not sure if these are related but wanted to report just in case. This would be my fourth pregnancy and first miscarriage, my other three pregnancies resulted in live births.
got sick; Initial information received on 20-Oct-2020 regarding an unsolicited valid non-serious case from a consumer (patient) via social media.  This case is linked to case ID: 2020SA297164.  This case involves a patient of unknown demographics who got sick (illness), after receiving INFLUENZA VACCINE.  The patient's medical history, past medical treatments, vaccinations, concomitant medications and family history were not provided.   On an unknown date, the patient received a dose of suspect INFLUENZA VACCINE produced by unknown manufacturer (batch number and expiration date not reported) via an unknown route in unknown administration site for prophylactic vaccination.  On an unknown date, the patient got sick (illness) (non-serious event) (unknown latency) following the administration of INFLUENZA VACCINE.  No laboratory data reported.  It was not reported if the patient received a corrective treatment.  At the time of report, the outcome was unknown for the event.  There will be no information on the batch number for this case.
Pt said arm pain that traveled down to elbow, then the other arm started to hurt at same spot. Lasted for over a week.
Local reaction 1 day after pneumococcal vaccine given, same arm. Complained of pain at site of injection. On exam: upper, outer right arm extending below elbow to below injection site is edematous, warm, firm with erythema, afebrile. Warm compresses, Motrin for pain, Benadryl ZS in AM and Erythromycin prescribed and given.
This spontaneous report as received from a nurse refers to unspecified number of patients of unknown age and gender. Medical history, concurrent conditions and concomitant medications were not reported. On an unknown date, the patients were vaccinated with VARIVAX (Merck) (dose, route and lot number were not provided). On an unknown date, the nurse reported that since unspecified date, improperly stored VARIVAX (Merck) was administered to patients and no adverse effects were noted. This is one of several reports received from the same reporter. Additional information has been requested.
BODY ACHE; CHILLS; DIARRHEA; FEVER; This spontaneous report received from a patient concerned a 60 year old male. The patient's height, and weight were not reported. The patient's concurrent conditions included chronic obstructive pulmonary disease, and high blood pressure, and other pre-existing medical conditions included the patient had no known allergies. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, intramuscular, batch number: 1805018, and batch number: 1805018) dose was not reported, once a total administered  on 10-MAR-2021 for prophylactic vaccination. No concomitant medications were reported. On 11-MAR-2021, the subject experienced body ache. On 11-MAR-2021, the subject experienced chills. On 11-MAR-2021, the subject experienced diarrhea. On 11-MAR-2021, the subject experienced fever. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from chills on 12-MAR-2021, was recovering from body ache, and had not recovered from fever, and diarrhea. This report was non-serious.
asymptomatic bilateral anterior uveitis; This literature marketed report has been received from the authors of a published literature article, titled as stated below and refers to 58-year-old female, with no history of autoimmune disease. Concomitant therapies were not provided.  On an unknown date, the patient was vaccinated with hepatitis B vaccine (recombinant) (manufacturer unknown) (dose, route, site of administration, lot # and expiration date not reported) for prophylaxis. Three weeks after vaccination, the patient experienced asymptomatic bilateral anterior uveitis. It was also reported, that uveitis following vaccination was with development of posterior synechiae in her right eye only. Then, due to the event, as she received her first "Moderna COVID-19 vaccine" on 25-FEB-2021, she also received an eye examinations by an ophthalmologist just after her vaccination and then weekly to evaluate for any ocular changes.   The outcome of the event asymptomatic bilateral anterior uveitis was unknown. The causality assessment between the suspect vaccine and the event was assessed as related.  After internal review, the event asymptomatic bilateral anterior uveitis was considered to be medically significant.   Literature report:   A copy of the published article is attached as further documentation of the patient's experience.
Patient with history of epilepsy presented for covid vaccine on4/27/21. Per other participants in the waiting area, initially, patient was shaking in the chair 10 minutes post covid vaccine injection.  then became rigid, the staff patient guided patient to the floor,  Denied LOC or head trauma . Other RN and MD arrived on scene, patient appeared to be in post-ictal phase: patient was lying on the floor, confused and disoriented, fingers and limbs were tense and rigid and patient unable to follow commands. VSS/WNL. Paramedics called - by the time their arrived patient was able to answer questions and follow commands. patient refused to go to hospital. RN sat with patient after paramedics left, at this time patient was A&Ox3, ambulating independently and  able to list medications, stated he sees a neurologist at the hospital- stated last appt was in February and the next follow up is in May. Incident report submitted and follow up appointment scheduled with PCP, ER precautions reviewed with patient.
Pt fainted after (meningococcal) on left arm. After child woke up, another MA helped me get him on table with nurse assistant. Pt mother & child both admitted that child, didn't eat breakfast, so we gave child juice & crackers = Pt felt better after 15min.
Had both Pfizer injections and within two months of the last dose, I was diagnosed with Graves disease. My labs drawn on 7/29/21 showed a TSH of <0.010. Previous labs have resulted in TSH of 2.3. I have no family history of Graves disease nor thyroid disease in my family. Prior to my diagnosis, I had memory loss, tremors, and heart palpitations before my thyroid became enlarged.
Administrated with the only the liquid component; Administrated with the only the liquid component; This case was reported by a nurse via call center representative and described the occurrence of wrong solution used in drug reconstitution in a 6-year-old male patient who received Men ACWY-CRM NVS (Menveo) (batch number amva714a, expiry date 30th June 2023) for prophylaxis.   On 16th August 2022, the patient received Menveo. On 16th August 2022, unknown after receiving Menveo, the patient experienced wrong solution used in drug reconstitution and inappropriate dose of vaccine administered. On an unknown date, the outcome of the wrong solution used in drug reconstitution and inappropriate dose of vaccine administered were unknown.   Additional Information: GSK receipt date- 18-Aug-2022 Reporter's comment: Nurse reported that a male patient was administrated with only the liquid component of Menveo. Adverse event was not reported. The reporter consented to follow up. Additional Supportive Information: The patient was administrated Menveo reconstituted with only the liquid component of Menveo, which led to wrong solution used in drug reconstitution and Inappropriate dose of vaccine administered.
PPSV23 given at 9:15. At 15:35 pt came back to clinic - left deltoid appeared in spasm. Doctor evaluated. Recommended heat/ice, ibuprofen, rest arm. 5/3/16 pt reports arm is improving. Patient referred to PT.
27JUN h/a, back of head stiff; n,v; 8JUL still h/a, welts, hives devel on arms, chest, legs; c/o arthralgia; 10JUL to ER; 11JUL to MD ?poison ivy; 14JUL to MD; 16JUL to neurologist MD; 4AUG h/a identified as occipital neurologia;
Information has been received from a physician at an university student health facility concerning a 22 year old female with a penicillin and amoxicillin allergies and no pertinent medical history who had no problems with her first dose of Gardasil and was vaccinated at a private physician's office with the second dose on 09-MAR-2007 of Gardasil. Concomitant therapy included unspecified hormonal contraceptives. On 09-MAR-2007 the patient experienced burning sensation in arm in which she was vaccinated as well as nausea. The patient stated that she was vaccinated high in her arm possibly in the joint space which caused her immediate discomfort. She thought the needle hit her joint. The patient sought unspecified medical attention. As of 19-MAR-2007 the patient continued to have pain in the arm and shoulder which she thought was due to the injection technique. The patient took ibuprofen which helped the pain. The patient planned to see someone in the sports-medicine department for further assessment. Additional information has been requested.
Pt recv vax on 4/24/99; approx 5 min post vax pt exp diaphoresis, pale color, quiet
Narrative: 30 yo F presenting to ED with two days of dry cough, body aches, generalized headache, rhinorrhea, sore throat, and sob. Pt reprots she had her COVID vaccine on Tuesday. Started feeling ill the day after (wed). Continued to feel worse today so wanted to come in to get tested to make sure she was not infeced. Pfizer vaccine. Endorses some chest tightness. On OCP. No history of DVT or PE. Decreased urine output. Tolerating po. Has not had tylenol or ibuprofen. No known fevers. +chills. +sweats. Was given APAP in ED. Discharged home.
got second j j shot on 11-4-2021 on 11-9-2021 felt like a sinus problem, headache,sore throat, blocked ears, bad cough,. Call my dr  she suggested a covid test. On 11-11-2021 I went to med express hermitage for a rapid test 2 1/2 hours later it was positive, notified my emloyer went home for next 10 days.  rested stayed in , will return to work 11-23-2021
This spontaneous report was received from a nurse referring to a patient of unknown age and gender. The patient's pertinent medical history, concurrent conditions or concomitant medications were not reported. On 04-OCT-2018, the patient was vaccinated with an improperly stored dose of ROTATEQ, orally, lot # N013885 (expiration date: 09-DEC-2018), for prophylaxis. No adverse effects were reported. The vaccine was exposed to a temperature excursion of 9-25 Celsius degrees for a timeframe of 1 hour and 9 minutes. It was found because of a digital data logger. There were no previous excursions.
COVID 19; COVID 19; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 76-year-old female patient received BNT162b2 (BNT162B2), on 04Apr2022 at 13:00 as dose 4 (booster), single (Lot number: Fj9943) at the age of 76 years, in left arm for covid-19 immunisation; coviD-19 vaccine (COVID-19 VACCINE), as dose 1, single (Batch/Lot number: unknown), as dose 2, single (Batch/Lot number: unknown) and as dose 3 (booster), single (Batch/Lot number: unknown) for covid-19 immunisation. The patient had no relevant medical history. The patient's concomitant medications were not reported. Past drug history included: Known allergies mo, reaction(s): "Known allergies Mo", notes: Known allergies Mo. The following information was reported: COVID-19 (medically significant) with onset 06May2022, outcome "recovering", DRUG INEFFECTIVE (medically significant) with onset 2022, outcome "unknown" and all described as "COVID 19". Therapeutic measures were taken as a result of drug ineffective, covid-19. Clinical course: Treatment received included Amici Clav857.
Patient presented in December 2022 for first dose of primary series Moderna COVID-19 vaccination. Patient was inadvertently administered Moderna bivalent booster vaccine instead of monovalent primary series formulation.
second dose received 0.25ml instead of 0.5ml; Vaccines that were administered beyond use date after thaw process; This spontaneous case was reported by a paramedic and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Vaccines that were administered beyond use date after thaw process) and UNDERDOSE (second dose received 0.25ml instead of 0.5ml) in a 71-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 027H21B) for COVID-19 prophylaxis.     No Medical History information was reported.    On 29-Dec-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) .25 milliliter. On 29-Dec-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (Vaccines that were administered beyond use date after thaw process). On an unknown date, the patient experienced UNDERDOSE (second dose received 0.25ml instead of 0.5ml). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Vaccines that were administered beyond use date after thaw process) and UNDERDOSE (second dose received 0.25ml instead of 0.5ml) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Concomitant product use was not provided by the reporter.  Patient age was reported as 71 years and 9 months.  On 10-Jun-2022, medical was notified about an audit that was done and they were then made aware of vaccines that were administered beyond use date after the thaw process. Reporter stated that there was no patient that had any adverse reactions and there were no reports of any reactions after the administration of vaccines. Vaccine NDC code was reported as 80777-0273-99.  Treatment information was not provided.   This case was linked to MOD-2022-542869 (Patient Link).
On 03/30/2021 I received a Fast COVID Test for an outpatient procedure and tested Positive for CODID 19. I have no COVID symptoms and feel fine. I have no known contact with anyone with COVID  and have consistently worn a mask and followed all protocols for the last year. I am quarantining at home and remain perplexed why I tested positive.
menstrual spotting that lasted for 4 days; migraine that lasted for 3 days; extreme body/joint aches that lasted for 2 days; stomach pain that lasted for 8 days
5OCT93 pt recvd vax & pt was receiving vax & became flushed & felt faint; MD administered 30cc DPH 5 mins later BP 160/82, pulse 80; pt sent home in approx 30 mins; pt recoverd; nurse reported pt very anxious & poss vasovagal react;
Symptoms started 30 min after the shot, and lasted for about 20 hours:  fatigue, bad headache, muscle and joint pain - especially in both legs and ankles and left arm and elbow joint;  chills, nausea, weakness in legs, upset stomach.
at approximately 2:13pm pt had a syncopal episode in the observation area of the clinic. Pt fell from chair to linoleum floor approximately 3 feet landing on his stomach, chest and right side of his face. an EMT in the observation area immediately called for help and attempted to rouse the patient. after being unconscious for about 15 seconds total, patient awoke and  knew his name, where he was, and what had happened. PT was sit-pick maneuvered to a stretcher in semi-fowlers position, taken to a private area and assessed. PT's head, neck and back were palpated for tenderness, deformity, injury and discomfort.  PT denied head neck and back pain. Upon assessment of mouth, pt did bite the tip of his tongue with a small amount of bleeding, approximately less than half a millimeter . Initial vital signs were taken at 2:16pm blood pressure 84/60, pulse rate 56, respiratory rate 18 lung sounds clear and equal in all 4 quadrants, pupils equal, round reactive to light, tracking motion, 4 mm in diameter.  PT questioning revealed prehypertensive, no known medical or food allergies, no over the counter or prescription medications, pt stated that he did have a  syncopal episode about 3 years ago when he was sick with the flu and bearing down on the toilet. PT stated  after he got the vaccine he sat down, was moving his arm, felt dizzy, blacked out, and woke up  on the floor. PT stated he was dizzy upon initial assessment, but other wise denied pain or discomfort. PT vitals Reassessed at 2:21pm BP 106/74, PR 60, RR18, LS clear PEARL -4mm. PT was instructed after about 30 minutes of observation to sit up for 2 minutes, PT denied dizziness or discomfort. PT instructed to stand in place for 2 minutes, pt denied dizziness or discomfort. PT  vital signs reassessed at 2:52 pm BP 134/86, PR 68, RR 18, LS clear, PEARRL 4mm. PT was escorted to his vehicle by a paramedic where his family was waiting to drive him home. PT was encouraged to seek additional medical attention as soon as possible for further evaluation. PT left clinic site at about 3:10pm
Had vaccine and had a red spot and sore arm which went away after a couple days. Four days after the vaccine a blood vessel in my hand burst (I don't recall hitting it on anything at all). It puffed up about a centimeter and slowly went away over a few days. Then a little more than a week later the red spot came back and itched very badly and was sore again. It also faded after several days. then yesterday morning I woke up and my arm was sore at the injection site again only I started having the worst headache of my life that lasted 30 hours. I started shaking, sweating massively, I felt hot and cold at the same time, felt as if I had a very high fever but my temperature was 98.4 (totally normal). I was vomiting if I tried to eat or drink. I had severe body aches and EXTREME weakness throughout my body. My heart began to race at 150-160 bpm for several hours and I couldn't sleep. It has gotten about 50%  better in the past few hours and will hopefully continue that way. I've never felt anything like it in my life. I need to know if it is safe for me to get the second shot.
Stating getting heat sensations in right eye. Went to eye dr.  Nothing was found wrong with the eye and was referred back to Primary Care Physician  found nothing wrong as well. Both doctors are stating they have never heard of anything causing heat to radiated off and on in the eye.  Primary had me try allergy med which has not helped. Still heat occurring with no explanation/diagnosis found. Currently still getting heat radiating in right eye with no diagnosis of why this keeps happening.
Patient here for 2nd dose Moderna,  Received 1st dose Moderna  04/1/2021 @ mass clinic site with Department of Health. Patient is 17 and does not meet age guidelines but received 1st dose therefore administered second dose
Injection site pain; This is a spontaneous report from a contactable consumer (patient). A 68-year-old male patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; Lot Number: EM9810), via an unspecified route of administration in left arm, on 09Feb2021 at 12:45 PM, at a single dose, for COVID-19 immunization. The patient had no medical history. The patient's concomitant medications included atorvastatin, fish oil, and an unspecified multivitamin. The patient had no known allergies. The patient was not diagnosed with COVID-19 prior vaccination. No other vaccine was administered in four weeks. The vaccine was administered in a hospital facility. On 09Feb2021 at 10:00 PM (22:00), the patient had injection site pain for 3 days. No treatment was received for the adverse event. The patient had not been tested for COVID-19 post vaccination. The patient recovered from the event on 12Feb2021.